文献速递产科

OdonAssist可充气装置用于辅助阴道分娩——ASSIST II研究(英国)

The OdonAssist inflatable device for assisted vaginal birth-the ASSIST II study (United Kingdom).
PubMed 文献 · Am J Obstet Gynecol · 2023-07-30

在英國布里斯托尔Southmead医院开展开放标签非随机研究,104名有临床指征的辅助阴道分娩参与者使用OdonAssist。104例中69例(66%)成功助产,无严重器械相关母婴不良反应;作者认为成功率满足开展随机对照试验的阈值,并指出可减少新生儿软组织损伤。

要点

  • 104例中69例(66%)使用OdonAssist成功助产,达到预设的良好有效率假设。
  • 无严重器械相关母婴不良反应或严重不良器械效应。
  • 成功组仅4%新生儿软组织瘀伤被认为与器械相关,失败组为20%,嵌套队列为23%。

核心结论

  • 招募新辅助阴道分娩器械的干预性研究可行,64%的合格参与者愿意参加。
  • OdonAssist成功率与2002年同一单位引入的Kiwi OmniCup相当,达到开展随机对照试验比较OdonAssist与当前标准实践的阈值。
  • 参与研究在母婴结局方面无劣势,使用OdonAssist可能有潜在优势,尤其是减少新生儿软组织损伤。

研究设计与样本

  • 开放标签非随机研究,在英国布里斯托尔Southmead医院开展,104名有临床指征的辅助阴道分娩参与者使用OdonAssist。
  • 另收集同意参加但无受过培训的OdonAssist操作者可用的参与者数据,构成嵌套队列。
  • 主要临床结局为使用OdonAssist成功加速分娩的比例;次要结局包括临床、患者报告、操作者报告、器械和卫生保健利用指标。
  • 新生儿结局数据在28天审查,产妇结局随访至90天。
  • 2019年8月至2021年6月期间,1471名符合条件并接洽的参与者中941名(64%)同意参加。

主要发现

  • 104例中OdonAssist有效69例(66%),与良好有效率假设一致。
  • 无严重器械相关母婴不良反应,无严重不良器械效应。
  • 成功OdonAssist组仅4%新生儿软组织瘀伤被认为与器械相关,失败OdonAssist组为20%,嵌套队列为23%。
  • 参与者报告高分娩感知评分,所有操作者认为器械使用简便。
  • 所有头位顶先露胎位、坐骨棘下≥1 cm所有站别(伴或不伴区域镇痛)均可行助产。

关键数值与推荐

  • 若104例中成功OdonAssist分娩≥61例,则拒绝50%的差率假设,接受≥65%的良好率假设。
  • 主要临床结局为使用OdonAssist成功加速分娩的比例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Decreasing rates of assisted vaginal birth have been paralleled with increasing rates of cesarean deliveries over the last 40 years. The OdonAssist is a novel device for assisted vaginal birth. Iterative changes to clinical parameters, device design, and technique have been made to improve device efficacy and usability. OBJECTIVE: This study aimed to determine if the feasibility, safety, and efficacy of the OdonAssist device were sufficient to justify conducting a future randomized controlled trial. STUDY DESIGN: An open-label nonrandomized study of 104 participants having a clinically indicated assisted vaginal birth using the OdonAssist was undertaken at Southmead Hospital, Bristol, United Kingdom. Data were also collected from participants who consented to participate in the study but for whom trained OdonAssist operators were not available, providing a nested cohort. The primary clinical outcome was the proportion of births successfully expedited with the OdonAssist. Secondary outcomes included clinical, patient-reported, operator-reported, device and health care utilization. Neonatal outcome data were reviewed at day 28, and maternal outcomes were investigated up to day 90. Given that the number of successful OdonAssist births was ≥61 out of 104, the hypothesis of a poor rate of 50% was rejected in favor of a good rate of ≥65%. RESULTS: Between August 2019 and June 2021, 941 (64%) of the 1471 approached, eligible participants consented to participate. Of these, 104 received the OdonAssist intervention. Birth was assisted in all cephalic vertex fetal positions, at all stations ≥1 cm below the ischial spines (with or without regional analgesia). The OdonAssist was effective in 69 of the 104 (66%) cases, consistent with the hypothesis of a good efficacy rate. There were no serious device-related maternal or neonatal adverse reactions, and there were no serious adverse device effects. Only 4% of neonatal soft tissue bruising in the successful OdonAssist group was considered device-related, as opposed to 20% and 23% in the unsuccessful OdonAssist group and the nested cohort, respectively. Participants reported high birth perception scores. All practitioners found the device use to be straightforward. CONCLUSION: Recruitment to an interventional study of a new device for assisted vaginal birth is feasible; 64% of eligible participants were willing to participate. The success rate of the OdonAssist was comparable to that of the Kiwi OmniCup when introduced in the same unit in 2002, meeting the threshold for a randomized controlled trial to compare the OdonAssist with current standard practice. There were no disadvantages of study participation in terms of maternal and neonatal outcomes. There were potential advantages of using the OdonAssist, particularly reduced neonatal soft tissue injury. The same application technique is used for all fetal positions, with all operators deeming the device straightforward to use. This study provides important data to inform future study design.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hotton EJ, Bale N, Rose C, et al. The OdonAssist inflatable device for assisted vaginal birth-the ASSIST II study (United Kingdom). Am J Obstet Gynecol. 2023. PMID: 38462264. doi:10.1016/j.ajog.2023.05.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。